These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 8070610)

  • 21. Effects of lisinopril and nifedipine on the progression to overt albuminuria in IDDM patients with incipient nephropathy and normal blood pressure. The Italian Microalbuminuria Study Group in IDDM.
    Crepaldi G; Carta Q; Deferrari G; Mangili R; Navalesi R; Santeusanio F; Spalluto A; Vanasia A; Villa GM; Nosadini R
    Diabetes Care; 1998 Jan; 21(1):104-10. PubMed ID: 9538979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Greater reduction of urinary albumin excretion in hypertensive type II diabetic patients with incipient nephropathy by lisinopril than by nifedipine.
    Agardh CD; Garcia-Puig J; Charbonnel B; Angelkort B; Barnett AH
    J Hum Hypertens; 1996 Mar; 10(3):185-92. PubMed ID: 8733038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BP and Renal Outcomes in Diabetic Kidney Disease: The Veterans Affairs Nephropathy in Diabetes Trial.
    Leehey DJ; Zhang JH; Emanuele NV; Whaley-Connell A; Palevsky PM; Reilly RF; Guarino P; Fried LF;
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2159-69. PubMed ID: 26482258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Captopril and atenolol are equally effective in retarding progression of diabetic nephropathy. Results of a 2-year prospective, randomized study.
    Elving LD; Wetzels JF; van Lier HJ; de Nobel E; Berden JH
    Diabetologia; 1994 Jun; 37(6):604-9. PubMed ID: 7926346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of cilazapril and amlodipine on kidney function in hypertensive NIDDM patients.
    Velussi M; Brocco E; Frigato F; Zolli M; Muollo B; Maioli M; Carraro A; Tonolo G; Fresu P; Cernigoi AM; Fioretto P; Nosadini R
    Diabetes; 1996 Feb; 45(2):216-22. PubMed ID: 8549868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimal dose of losartan for renoprotection in diabetic nephropathy.
    Andersen S; Rossing P; Juhl TR; Deinum J; Parving HH
    Nephrol Dial Transplant; 2002 Aug; 17(8):1413-8. PubMed ID: 12147788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimal dose of lisinopril for renoprotection in type 1 diabetic patients with diabetic nephropathy: a randomised crossover trial.
    Schjoedt KJ; Astrup AS; Persson F; Frandsen E; Boomsma F; Rossing K; Tarnow L; Rossing P; Parving HH
    Diabetologia; 2009 Jan; 52(1):46-9. PubMed ID: 18974967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term beneficial effect of ACE inhibition on diabetic nephropathy in normotensive type 1 diabetic patients.
    Parving HH; Hommel E; Jensen BR; Hansen HP
    Kidney Int; 2001 Jul; 60(1):228-34. PubMed ID: 11422755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber M; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T
    Arch Intern Med; 2005 Apr; 165(8):936-46. PubMed ID: 15851647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence of a threshold value of glycated hemoglobin to improve the course of renal function in type 2 diabetes with typical diabetic glomerulopathy.
    Brocco E; Velussi M; Cernigoi AM; Abaterusso C; Bruseghin M; Carraro A; Sambataro M; Piarulli F; Sfriso A; Nosadini R
    J Nephrol; 2001; 14(6):461-71. PubMed ID: 11783602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lisinopril reduces postexercise albuminuria more effectively than atenolol in primary hypertension.
    Rangemark C; Lind H; Lindholm L; Hedner T; Samuelsson O
    Eur J Clin Pharmacol; 1996; 49(4):267-71. PubMed ID: 8857071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of nisoldipine and lisinopril on microvascular dysfunction in hypertensive Type I diabetes patients with nephropathy.
    Sørensen VB; Rossing P; Tarnow L; Parving H; Nørgaard T; Kastrup J
    Clin Sci (Lond); 1998 Dec; 95(6):709-17. PubMed ID: 9831696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of acetazolamide on kidney function in type 1 (insulin-dependent) diabetic patients with diabetic nephropathy.
    Skøtt P; Hommel E; Bruun NE; Arnold-Larsen S; Parving HH
    Diabetologia; 1988 Nov; 31(11):806-10. PubMed ID: 3234635
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiotensin-converting enzyme inhibition in diabetic nephropathy: ten years' experience.
    Parving HH; Rossing P; Hommel E; Smidt UM
    Am J Kidney Dis; 1995 Jul; 26(1):99-107. PubMed ID: 7611276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy.
    Bakris GL; Copley JB; Vicknair N; Sadler R; Leurgans S
    Kidney Int; 1996 Nov; 50(5):1641-50. PubMed ID: 8914031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of ACE inhibitors on renal function in incipient and overt diabetic nephropathy.
    Parving HH
    J Diabetes Complications; 1996; 10(3):133-5. PubMed ID: 8807457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential pharmacodynamic drug-drug interaction between concomitantly administered lisinopril and diclofenac sodium: a call for appropriate management in hypertensive osteoarthritic patients.
    Goswami SK; Jain S; Chudasama H; Santani D
    Drug Metabol Drug Interact; 2011; 26(3):127-37. PubMed ID: 21980964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Placebo-controlled trial of lisinopril in normotensive diabetic patients with incipient nephropathy.
    O'Donnell MJ; Rowe BR; Lawson N; Horton A; Gyde OH; Barnett AH
    J Hum Hypertens; 1993 Aug; 7(4):327-32. PubMed ID: 8410923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative antihypertensive and renoprotective effects of telmisartan and lisinopril after long-term treatment in hypertensive diabetic rats.
    Wienen W; Richard S; Champeroux P; Audeval-Gerard C
    J Renin Angiotensin Aldosterone Syst; 2001 Mar; 2(1):31-6. PubMed ID: 11881063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulse pressure lowering effect of dual blockade with candesartan and lisinopril vs. high-dose ACE inhibition in hypertensive type 2 diabetic subjects: a CALM II study post-hoc analysis.
    Knudsen ST; Andersen NH; Poulsen SH; Eiskjaer H; Hansen KW; Helleberg K; Poulsen PL; Mogensen CE
    Am J Hypertens; 2008 Feb; 21(2):172-6. PubMed ID: 18188164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.